| Direct Competitor Comparison | |
|---|
| PSDV | AGN | LLY | PVT1 | Industry |
|---|
| Market Cap: | 125.34M | 26.95B | 54.73B | N/A | N/A |
|---|
| Employees: | N/A | N/A | N/A | N/A | N/A |
|---|
| Qtrly Rev Growth (yoy): | N/A | N/A | N/A | N/A | 0.00 |
|---|
| Revenue (ttm):
| N/A | N/A | N/A | N/A | N/A |
|---|
| Gross Margin (ttm): | N/A | N/A | N/A | N/A | 0.00 |
|---|
| EBITDA (ttm): | N/A | N/A | N/A | N/A | N/A |
|---|
| Operating Margin (ttm):
| N/A | N/A | N/A | N/A | 0.00 |
|---|
| Net Income (ttm): | N/A | N/A | N/A | N/A | N/A |
|---|
| EPS (ttm): | N/A | N/A | N/A | N/A | N/A |
|---|
| P/E (ttm): | N/A | N/A | N/A | N/A | N/A |
|---|
| PEG (5 yr expected): | N/A | 1.43 | -3.29 | N/A | N/A |
|---|
| P/S (ttm): | 44.68 | 4.43 | 2.37 | N/A | N/A |
|---|
|
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Amgen Inc. | AMGN | 114.58 | 0.02 | 86.32B | N/A |
|---|
| Genentech, Inc. | Private - View Profile |
|---|
| Biogen Idec Inc. | BIIB | 244.92 | 0.02 | 58.21B | N/A |
|---|
| Genzyme Corporation | Private - View Profile |
|---|
| Merck Serono S.A. | Private - View Profile |
|---|
| Gilead Sciences Inc. | GILD | 62.80 | -0.00 | 96.12B | N/A |
|---|
| MedImmune, L.L.C. | Private - View Profile |
|---|
| Life Technologies Corporation | LIFE | 74.87 | 0.00 | 12.93B | N/A |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 37.69 | -0.00 | 31.85B | N/A |
|---|
| Sandoz International GmbH | Private - View Profile |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Actavis, Inc. | ACT | 145.10 | 0.01 | 19.32B | N/A |
|---|
| Ranbaxy Laboratories Limited | Private - View Profile |
|---|
| Mylan, Inc. | MYL | 39.45 | 0.03 | 15.06B | N/A |
|---|
| Pfizer Inc. | PFE | 28.89 | 0.01 | 191.26B | 8.02 |
|---|
| Johnson & Johnson | JNJ | 87.47 | 0.01 | 246.50B | N/A |
|---|
| GlaxoSmithKline plc | GSK | 50.56 | 0.01 | 122.48B | N/A |
|---|
| Sanofi | SNY | 51.17 | 0.01 | 135.69B | N/A |
|---|
| Novartis AG | NVS | 76.72 | 0.00 | 187.77B | N/A |
|---|
| Roche Holding AG | RHHBY | 67.73 | 0.00 | 229.48B | N/A |
|---|
| AstraZeneca PLC | AZN | 51.92 | -0.00 | 65.00B | N/A |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Abbott Laboratories | ABT | 33.78 | 0.02 | 52.50B | N/A |
|---|
| Bristol-Myers Squibb Company | BMY | 47.24 | 0.02 | 77.77B | N/A |
|---|
|
| News on Direct Competitors | |
|---|
Currency in USD. | |
|
1.27(30.90%) Oct 1, 4:00PM EDT|After Hours
:
5.46